¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"Laboratory evidence of human immunodeficiency virus"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • human diploid cell vaccine
    »ç¶÷µÎ¹è¼ö¼¼Æ÷¹é½Å
  • human ecology
    Àηù»ýÅÂÇÐ
  • human experiment
    ÀÎü½ÇÇè
  • human genetics
    »ç¶÷À¯ÀüÇÐ
  • Human Genome Project
    Àΰ£À¯Àüü»ç¾÷
  • human histocompatibility antigen
    »ç¶÷Á¶Á÷ÀûÇÕ¼ºÇ׿ø
  • human leukocyte antigen
    »ç¶÷¹éÇ÷±¸Ç׿ø
  • human leukocyte antigen complex
    »ç¶÷¹éÇ÷±¸Ç׿øº¹ÇÕü
  • human leukocyte antigen complex gene
    »ç¶÷¹éÇ÷±¸Ç׿øº¹ÇÕüÀ¯ÀüÀÚ
  • human menopausal gonadotropin
    »ç¶÷Æó°æ»ý½Ä»ùÀÚ±ØÈ£¸£¸ó, »ç¶÷Æó°æ¼º¼±ÀÚ±ØÈ£¸£¸ó
  • human placental lactogen
    »ç¶÷ŹÝÁ¥»ùÀÚ±ØÈ£¸£¸ó, »ç¶÷ŹݶôÅä°Õ
  • human plasma protein fraction
    »ç¶÷Ç÷Àå´Ü¹éºÐÀ²
  • human rabies immune globulin
    »ç¶÷¹ÌÄ£°³º´¸é¿ª±Û·ÎºÒ¸°, »ç¶÷±¤°ßº´¸é¿ª±Û·ÎºÒ¸°
  • immune human serum globulin
    ¸é¿ª»ç¶÷Ç÷û±Û·ÎºÒ¸°
  • normal human plasma
    Á¤»ó»ç¶÷Ç÷Àå
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • adeno-associated virus
    ¾Æµ¥³ë¹ÙÀÌ·¯½ºÀÇÁ¸¹ÙÀÌ·¯½º
  • adeno-satellite virus
    ¾Æµ¥³ë¹ÙÀÌ·¯½ºÀ§¼º¹ÙÀÌ·¯½º
  • adventitious virus
    ¿ì¹ß¹ÙÀÌ·¯½º
  • attenuated virus
    ¾àµ¶È­¹ÙÀÌ·¯½º
  • avipox virus
    Á¶·ùÆø½º¹ÙÀÌ·¯½º
  • cell-associated virus
    ¼¼Æ÷ºÎÂø¹ÙÀÌ·¯½º
  • challenge virus
    °ø°Ý¿ë¹ÙÀÌ·¯½º, Á¢Á¾¹ÙÀÌ·¯½º
  • croup-associated virus
    Å©·ì°ü·Ã¹ÙÀÌ·¯½º
  • dermatotropic virus
    ÇǺÎģȭ¹ÙÀÌ·¯½º
  • DNA virus
    µð¿£¿¡À̹ÙÀÌ·¯½º
  • enveloped virus
    ²®Áúº¸À¯¹ÙÀÌ·¯½º
  • foamy virus
    °ÅǰÇü¼º¹ÙÀÌ·¯½º
  • virus inhibitory factor
    ¹ÙÀÌ·¯½º¾ïÁ¦ÀÎÀÚ
  • helper virus
    º¸Á¶¹ÙÀÌ·¯½º, Á¶·Â¹ÙÀÌ·¯½º
  • hemadsorption virus
    Ç÷±¸ÈíÂø¹ÙÀÌ·¯½º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • acquired immunodeficiency syndrome (AIDS)
    ÈÄõ¼º¸é¿ª°áÇÌÁõ(Èıº)
  • acquired immunodeficiency syndrome(AIDS)
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • immunodeficiency
    ¸é¿ª°áÇÌ.
  • immunodeficiency
    ¸é¿ª°áÇÌ(Øóæ¹ÌÀù¹)
  • immunodeficiency
    ¸é¿ª°áÇÌ
  • immunodeficiency detection
    ¸é¿ª°áÇ̰ËÃâ
  • immunodeficiency disease
    ¸é¿ª°áÇÌÁúȯ
  • immunodeficiency syndrome, acquired
    ÈÄõ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • immunodeficiency syndrome, cell mediated
    ¼¼Æ÷¸Å°³ ¸é¿ª°áÇÌ ÁõÈıº
  • immunodeficiency syndrome, combine
    º¹ÇÕÇü ¸é¿ª°áÇÌ Áõ (Èıº)
  • immunodeficiency syndrome, congenital
    ¼±Ãµ¼º ¸é¿ª°áÇÌ ÁõÈıº
  • immunodeficiency syndrome, primary
    ÀÏÂ÷¼º ¸é¿ª°áÇÌ ÁõÈıº, ¿ø¹ß¼º ¸é¿ª°áÇÌ ÁõÈıº
  • immunodeficiency syndrome, secondary
    ÀÌÂ÷¼º ¸é¿ª°áÇÌ ÁõÈıº, ¼Ó¹ß¼º ¸é¿ª°áÇÌ ÁõÈıº
  • immunodeficiency syndrome, severe combined
    ÁßÁõº¹ÇÕÇü ¸é¿ª°áÇÌ ÁõÈıº
  • primary immunodeficiency
    ¿ø¹ß¼º ¸é¿ª°áÇÌ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • type III human T lymphotropic virus
    IIIÇü ÀÎ t¸²ÇÁ¿µ¾ç¼º ¹ÙÀÌ·¯½º
  • biologics control laboratory
    [º´¸®,¹Ì»ý,±â»ý,¸é¿ª,¹ÙÀÌ,¿¹¹æ]»ý¹°Á¦Á¦°ü¸®½ÃÇè¼Ò(Ë×ËÑ̡̡˴ËöËàÌ´ËÛ).
  • biologics control laboratory
    º´¸®,¹Ì»ý,±â»ý,¸é¿ª,¹ÙÀÌ,¿¹¹æ»ý¹°Á¦Á¦°ü¸®½ÃÇè¼Ò(ßæÚªð²ð¥Î·ìµãËúÐá¶).
  • clinical laboratory
    ÀÓ»ó°Ë»ç½Ç
  • dental laboratory
    Ä¡°ú±â°ø½Ç(¡­ÐüÍïãø).
  • dental laboratory technician
    Ä¡°ú±â°ø»ç.
  • inspection of laboratory
    ½ÇÇè½Ç<°Ë»ç½Ç>Á¡°Ë<--°Ë¿­>
  • laboratory accreditation
    °Ë»ç½Ç½ÅÀÓÀå
  • laboratory activity
    °Ë»ç½ÇȰµ¿
  • laboratory animal
    ½ÇÇ赿¹°
  • laboratory certification
    °Ë»ç½ÇÁõ¸í¼­
  • laboratory communication
    °Ë»ç½ÇÀÇ»ç¼ÒÅë
  • laboratory design
    °Ë»ç½Ç°èȹ
  • laboratory director
    °Ë»ç½Ç Ã¥ÀÓÀÚ<Àå ÁöµµÀÚ
  • laboratory equipment
    °Ë»ç½ÇÀåºñ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • sendai virus
    ¼¾´ÙÀÌ ¹ÙÀÌ·¯½º
  • simian virus 40
    ½Ã¹Ì¾È ¹ÙÀÌ·¯½º40
  • slow virus
    ½½·Î ¹ÙÀÌ·¯½º
  • tumor virus
    Á¾¾ç(ðþåË)¹ÙÀÌ·¯½º
  • type A RNA virus
    AÇü(úþ) RNA ¹ÙÀÌ·¯½º
  • type B RNA virus
    BÇü(úþ) RNA ¹ÙÀÌ·¯½º
  • type C virus
    CÇü(úþ) ¹ÙÀÌ·¯½º
  • type C RNA virus
    CÇü(úþ) RNA ¹ÙÀÌ·¯½º
  • virus
    ¹ÙÀÌ·¯½º
  • virus antigen
    ¹ÙÀÌ·¯½º Ç׿ø (ù÷ê«)
  • virus receptor
    ¹ÙÀÌ·¯½º ¼ö¿ëü (â¥é»ô÷)
  • virus theory of cancer
    ¹ÙÀÌ·¯½º ¾Ï¹ß»ý·Ð(äßÛ¡ßæÖå)
  • xenotropic virus
    Ä£(öÑ)ÀÌÁ¾(ì¶ðú) ¹ÙÀÌ·¯½º
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
ABL abetalipoproteinemia; acceptable blood loss; African Burkitt lymphoma; Albright-Butler-Lightwood [sy...
CLT Certified Laboratory Technician; chronic lymphocytic thyroiditis; Clinical Laboratory Technician; cl...
CLT(NCA) Laboratory Technician Certified by the National Certification Agency for Medical Laboratory Personne...
CS(NCA) Clinical Laboratory Scientist Certified by the National Certification Agency for Medical Laboratory ...
IL ileum; incisolingual; independent laboratory; iliolumbar; independent laboratory; inspiratory load; ...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
HIV-2 Human Immunodeficiency Virus type 1 and type 2
HIV-2 Human Immunodeficiency Virus type 2
HIV-I Human Immunodeficiency Virus type I
Hivan Human immunodeficiency virus associated nephropathy
HIV Human immunodeficiency virus infection
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • citrated normal human plasma
    Á¤»óÀÎ ±¸¿¬»ê¿° ÷°¡ Ç÷Àå
  • class I human leukocyte antigen
    Á¦ 1±Þ ÀÎü ¹éÇ÷±¸ Ç׿ø
  • class II human leukocyte antigen
    Á¦ 2±Þ ÀÎü ¹éÇ÷±¸ Ç׿ø
  • human bite
    »ç¶÷ ±³»ó
  • human chorionic gonadotropin
    »ç¶÷ À¶¸ð¼º ¼º¼± ÀÚ±Ø È£¸£¸ó
    ÀÌ´Â glyco
  • human counter
    Àü½Å °è¼ö ÀåÄ¡
    µ¿ÀǾî=whole body counter.
  • human ecology
    Àΰ£ »ýÅÂÇÐ, Àηù »ýÅÂÇÐ
    Àΰ£°ú ȯ°æ°úÀÇ »óÈ£ ÀÛ¿ëÀ» ¿¬±¸ÇÏ´Â »ý¹°ÇÐÀÇ ÇÑ ºÐ¾ß.
  • human fetal membrane
    »ç¶÷ ÅÂ¾Æ ¸·
  • human genome
    Àΰ£ °Ô³ð
  • human growth hormone
    ¼ºÀå È£¸£¸ó
    ¼ºÀåÀ» ÃËÁøÇÏ´Â ¹°ÁúÀ» ÃÑĪÇϸç, ƯÈ÷ ³úÇϼöü Àü¿±¿¡¼­ ºÐºñµÇ´Â È£¸£¸óÀ» ¸»ÇÑ´Ù.
  • human histocompatibility antigen
    ÀÎü Á¶Á÷ ÀûÇÕ Ç׿ø
  • human leukocyte antigen-B27
    ÀÎü ¹éÇ÷±¸ Ç×ü-B27
    º¸Åë °­Á÷¼º ôÃß¿° ȯÀÚ¿¡¼­ ³ªÅ¸³ª´Â À¯Àü Ç¥½ÃÀÚ.
  • human menopausal gonadotropin
    Æä°æ ¿©¼º ¼º¼± ÀÚ±Ø È£¸£¸ó
  • human oncovirus
    »ç¶÷ ¾Ï ¹ÙÀÌ·¯½º
  • human parvovirus-like agent
    »ç¶÷ ÆÄº¸ ¹ÙÀÌ·¯½º À¯»çü
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
herpes virus 6, human The type species of roseolovirus isolated from patients with aids and other lymphoproliferative disorders. It infects and replicates in fresh and established lines of haematopoietic cells and cells of neural origin. It also appears to alter nk cell activity. Hhv-6 (hblv) antibodies are elevated in patients with aids, sjogren's syndrome, sarcoidosis, chronic fatigue syndrome, and certain malignancies. Hhv-6 is the cause of exanthema subitum and has been implicated in encephalitis.
(12 Dec 1998)
herpes virus 7, human A species of the family herpesviridae isolated from activated, CD4-positive T-lymphocytes taken from the blood of a healthy human.
(12 Dec 1998)
human papilloma virus <virology> A disease caused by the human papilloma virus characterised by a soft wart-like growth on the genitalia (for example penis, vulva). In adults this infection is most commonly transmitted sexually. Genital warts are very common and are increasing in incidence.
Safe sex practices, such as using condoms can help decrease the risk of infection.
Treatment includes several topical agents to eradicate the lesions, cryosurgery, laser therapy, electrocauterisation or surgical removal.
See: alternate name condyloma acuminata.
Acronym: HPV
(27 Sep 1997)
human T-cell leukaemia virus <virology> One of a group of retroviruses which causes the disease T-cell leukaemia in humans. T-cell leukaemia is a type of the cancer leukaemia where the body uncontrollably produces large amounts of abnormal (nonworking) T lymphocytes.
(09 Oct 1997)
human T-cell lymphoma/leukaemia virus A group of viruses (subfamily Oncovirinae, family Retroviridae) that are lymphotropic with a selective affinity for the helper/inducer cell subset of T lymphocytes and that are associated with adult T-cell leukaemia and lymphoma.
Synonym: human T-cell lymphotropic virus.
(05 Mar 2000)
human T-cell lymphotropic virus A group of viruses (subfamily Oncovirinae, family Retroviridae) that are lymphotropic with a selective affinity for the helper/inducer cell subset of T lymphocytes and that are associated with adult T-cell leukaemia and lymphoma.
Synonym: human T-cell lymphotropic virus.
(05 Mar 2000)
human T lymphotrophic virus A virus that has a predilection for human lymphoid cells.
(05 Mar 2000)
human t-lymphotropic virus <virology> Type i: A human, single-stranded RNA retrovirus from the subfamily Oncovirinae which causes adult T-cell leukaemia and T-cell lymphoma and may also be involved in certain demyelinating diseases (diseases where the protective myelin sheath around nerve fibres are destroyed). HTLV-I is closely related to HTLV-II (60% of their genomes are identical).
Type II: A human, single-stranded RNA retrovirus from the subfamily Oncovirinae which may cause diseases such as T-cell leukaemia and T-cell lymphoma (but this has not been proven). HTLV-II is closely related to HTLV I (60% of their genomes are identical).
Type III: An obsolete term for human immunodeficiency virus (HIV), which causes Acquired Immunity Deficiency Syndrome (AIDS).
Acronym: HTLV
(09 Oct 1997)
influenza a virus, human Strains of influenza a virus causing influenza and sometimes pneumonia in humans. Transmission is by aerosol.
(12 Dec 1998)
enteric cytopathogenic human orphan virus eCHO virus
acquired immunodeficiency disease Acquired immunodeficiency disease: Disease caused by infection with the human immunodeficiency virus (HIV).
(12 Dec 1998)
Acquired Immunodeficiency Syndrome <immunology, syndrome> An epidemic disease caused by an infection by human immunodeficiency virus (HIV-1, HIV-2), a retrovirus that causes immune system failure and debilitation and is often accompanied by infections such as tuberculosis. AIDS is spread through direct contact with bodily fluids.
Acronym: AIDS
(10 May 1997)
malignancy and immunodeficiency <radiology> High risk of malignancy (especially lymphoma/leukaemia, GI tumours): X-linked agammaglobulinaemia (Bruton's), common variable immunodeficiency, severe combined immunodeficiency (SCID kids), ataxia-telangectasia, Wiscott-Aldrich syndrome, selective IgA deficiency
(12 Dec 1998)
cellular immunodeficiency with abnormal immunoglobulin synthesis An ill-defined group of sporadic disorders of unknown cause, occurring in both males and females and associated with recurrent bacterial, fungal, protozoal, and viral infections; there is thymic hypoplasia with depressed cellular (T-lymphocyte) immunity combined with defective humoral (B-lymphocyte) immunity, although immunoglobulin levels may be normal.
Synonym: Nezelof syndrome, Nezelof type of thymic alymphoplasia.
(05 Mar 2000)
phagocytic dysfunction disorders immunodeficiency Suppression in number or function of phagocytic cells such as in chronic granulomatous disease.
Synonym: phagocytic dysfunction disorders immunodeficiency.
Origin: L. Phagedaena, Gr Phago, To eat.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • Human Society
    µ¿¹° ¾ÖÈ£ Çùȸ;¼ö³­ ±¸Á¶È¸
  • human
    »ç¶÷ÀÇ;Àΰ£ÀûÀÎ;Àΰ£¿¡°Ô Àֱ⠽¬¿î
  • human document
    Àΰ£±â·Ï
  • human ecology
    Àΰ£ »ýÅÂÇÐ
  • human engineering
    Àΰ£°øÇÐ
  • human figure
    =Human One
  • human geography
    Àι®Áö¸®ÇÐ
  • human growth hormone
    Àΰ£¼ºÀå È£¸£¸ó(ÀÎüÀÇ ¼ºÀåÀ» Áö¹èÇÏ´Â ³úÇϼöü Á¾ÇÕ È£¸£¸ó)
  • human nature
    Àμº;Àΰ£¼º;ÀÎÁ¤
  • human potentials movement
    Àΰ£ ÀáÀç ´É·Â È¸º¹ ¿îµ¿(ÀÏÁ¾ÀÇ Áý´Ü ¿ä¹ýÀû ¼ö¾ç ¿îµ¿)
  • human power
    ÀÎÀû ÀÚ¿ø
  • human race
    Àηù 
  • human relations
    Àΰ£ °ü°è;´ëÀÎ °ü°è
  • human resource administration
    ÀÎÀû ÀÚ¿ø °ü¸®(Á¾¾÷¿øÀÇ °í¿ë,ÇØ°í,ºÒ¸¸ ó¸® µîÀÇ Àλç°ü¸®)
  • human rights
    (±âº»Àû)ÀαÇ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á